Previous 10 |
Aspira Women’s Health (NASDAQ: AWH ) : Q2 GAAP EPS of -$0.04. More news on: Aspira Women's Health Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
AUSTIN, Texas, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“ASPIRA”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the second quarter ended June 30, 2020. ...
AUSTIN, Texas, July 31, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it will report financial results for the second quarter ended June 30, 2020 on Thursday, August 13, 2020 after the market c...
Aspira Women's Health ( AWH -8.6% ) along with its investors, including Jack W. Schuler affiliates, its largest stockholder, have agreed to purchase ~$11M of unregistered shares of ASPIRA's common stock in a private placement at $3.50/share. More news on: Aspira Women's Health Inc...
AUSTIN, Texas, July 01, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) (“ASPIRA”), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that investors, including certain affiliates of Jack W. Schuler, ASP...
• Study evaluates ovarian cancer risk detection in pre-menopausal women • Patients with and without genetic predisposition that are not planning surgery to be monitored with OVANex AUSTIN, Texas, June 29, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, I...
Vermillion (NASDAQ: VRML ) has changed its name to Aspira Women’s Health (NYSE: AWH ), effective today and will trade on the Nasdaq Stock Market under the new ticker symbol “AWH” and a new CUSIP (04537Y109), effective June 12. More news on: Vermillion, Inc., Allied W...
News, Short Squeeze, Breakout and More Instantly...
Aspira Women's Health Inc. Company Name:
AWH Stock Symbol:
NASDAQ Market:
Aspira Women's Health Inc. Website:
Preliminary OvaWatch ® volume during Q2 2024 grew 24% over the prior quarter to 1,307 units Preliminary OvaSuite SM volume during Q2 2024 grew 11% over the prior quarter to 6,471 units AUSTIN, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Heal...
AUSTIN, Texas, July 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that i...
AUSTIN, Texas, July 01, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced it has...